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Table 1. Annual decline in GFR (mL/min 3 1.73 m2 body surfacethe laparoscopic donor nephrectomy, complications de-
area per year) during 3.2 years of follow-up according
crease with surgical experience. There are methods to to smoking status
help shorten this learning curve, including the use of
Moderate Heavy Phand-assist devices and a team approach. Indeed, our Non-smokers smokers smokers (ANOVA)
success has been due to the close working relationship
Men 2.663.9 3.863.7 4.564.6 .0.20
between experienced laparoscopic and transplant sur- N 40 13 4
CGN 2.5 63.9 3.663.5 5.364.6 .0.20geons.
N 33 6 4
Lloyd Ratner, D, Robert Montgomery Data are mean 6 SD.
Definitions are: nonsmokers, never smokers and ex-smokers; moderate smok-and Louis R. Kavoussi
ers, smoking less than 25 g/day; heavy smokers, smoking more than 25 g/day;The Comprehensive Transplant Center
CGN, chronic glomerulonephritis.and Brady Urological Institute
Johns Hopkins Medical Institutions
Baltimore, Maryland, USA
follow-up. Table 1 presents the change in GFR in men,REFERENCES
and in patients with chronic glomerulonephritis (CGN).1. Flowers JL, Jacobs S, Cho E, Morton A, Rosenberger WF, Evans
Although no statistically significant differences were pres-D, Imbembo AL, Bartlett ST: Comparison of open and laparoscopic
live donor nephrectomy. Ann Surg 226:483–489, 1997 ent, these data suggest a role for smoking in these particu-
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3. McFayden BV Jr, Vecchio R, Ricardo AE, Mathis CR: Bile renal damage seems to be less clear than in atherosclerosis.
duct injury after laparoscopic cholecystectomy: The United States Further prospective data are needed to determine its roleexperience. Surg Endos 12:315–321, 1998
in chronic renal disease in relation to other well-docu-
mented progression factors such as hypertension, protein-
uria and dyslipidemia.
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To the Editor: Smoking has recently been discussed as
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a risk factor for progression of renal insufficiency. This
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We performed a prospective study of 73 patients with
primary renal disease with the aim of evaluating the role
of renal dyslipidemia for the progression of renal failure
[4]. In a post-hoc analysis, smoking status (at entry) was The filtered complement
related to the decline in glomerular filtration rate (GFR).
There was no significant difference in the progression rate hypothesis
between smokers and nonsmokers during a three-year
To the Editor: In a recent Supplement to Kidney Inter-
national entitled, “Progression of Renal Disease: Proceed-
ings of the Verona Seminar on Nephrology” (Suppl 75,Ó 2000 by the International Society of Nephrology
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April 2000), various pathogenic aspects pertinent to the those with rapidly progressive nonselective proteinuria
such as diabetic glomerulosclerosis and focal segmentalprogressive nature of renal disease were discussed [1].
glomerulonephritis, excrete large amounts of comple-However, there was no mention of the potential patho-
ment degradation products in their urine, whereas nor-logic role that filtered complement might play in initiat-
mals and patients with minimal change nephropathying the tubulointerstitial damage that frequently accom-
have little or none [6]. Patients with IgA and membra-panies proteinuric glomerular disease states.
nous nephropathy have variable but lesser amounts.About 25 years ago, Sato and Ullrich [2] described a
The filtered complement hypothesis is straightforwardvery dramatic finding when fresh autologous serum was
and is compatible with the following clinical observa-microperfused into rat proximal tubule. Tubules were
tions: (1) patients with glomerular diseases associatedimmediately rendered incapable of transporting salt and
with nonselective proteinuria, particularly when protein-water as measured by the split drop technique, the intra-
uria is excessive, progress more rapidly into renal failurecellular potential difference depolarized and luminal cell
than patients with selective proteinuria; (2) morphologi-membrane resistance was virtually abolished all within
cally, tubulointerstitial damage correlates with progres-two minutes after luminal perfusion of serum [3]. Heter-
sive decline in kidney function better than frequency ofologous rat serum was equally effective as was fresh
glomerulosclerosis; (3) controlling blood pressure slowsserum from human, cat and rabbit, but not serum from
deterioration in renal function, particularly if proteinuriamouse or guinea pig. Morphologically, tubules perfused
declines; and (4) angiotensin-converting enzyme (ACE)with autologous serum were easily distinguished from
inhibitors, if associated with a significant decline in pro-adjacent tubules by obvious signs of cellular damage,
teinuria, slow the progress toward end stage.including vacuolization, mitochondrial swelling and loss
The filtered complement hypothesis suggests severalof brush borders associated with intraluminal accumula-
new therapeutic approaches. These include deactivationtion of cellular debris [4]. Sato and Ullrich concluded that
of MAC complexes formed at tubular brush bordersthe toxic effect of fresh serum was due to complement-
and exploitation of mechanisms to decrease glomerularactivated lysis of the proximal tubule apical membrane.
permeability to macromolecules.Amazingly, these studies were never confirmed by others
despite the obvious clinical implications. Carl J. Bentzel
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